26/05/22
2026/05/22
管理员
New progress has been made in near-infrared II (NIR-II) photoacoustic dual-responsive hyaluronic acid–coated nanozyme–based targeted theranostics for glioblastoma. Researchers Wu Xilong and Wu Yundi f
Learn More26/05/22
2026/05/22
管理员
New progress has been made in the study of osimertinib resistance mechanisms in EGFR-mutant non-small cell lung cancer (NSCLC). Research teams led by Richeng Jiang and Dingzhi Huang from Tianjin Medic
Learn More26/05/14
2026/05/14
管理员
New progress has been made in the development of targeted nanomedicines for peritoneal metastasis of colorectal cancer.
Learn More26/05/14
2026/05/14
管理员
New progress has been made in organelle therapy based on mitochondrial capsule delivery systems for the treatment of Parkinson’s disease and other mitochondrial dysfunction-related disorders.
Learn More26/05/04
2026/05/04
管理员
New progress has been made in multifunctional nanocatalytic tumor theranostics.
Learn More26/05/04
2026/05/04
管理员
New progress has been made in the molecular regulatory mechanisms of poplar resistance to rust fungi.
Learn More26/04/28
2026/04/28
管理员
New progress has been made in skin wound repair and regenerative medicine, particularly through the regulation of macrophage polarization.
Learn More26/04/28
2026/04/28
管理员
New progress has been made in identifying novel targets for cancer immunotherapy through single-cell screening.
Learn More